Status:

COMPLETED

Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)

Lead Sponsor:

University Hospital, Angers

Collaborating Sponsors:

Fondation Apicil

Conditions:

Pain, Postoperative

Cardiac Surgery

Eligibility:

All Genders

18-100 years

Phase:

PHASE3

Brief Summary

The main objective is to compare the effectiveness of LocoRegional Anesthesia (LRA) (bilateral transverse thoracic block or bilateral parasternal block) in addition to standard management compared to ...

Detailed Description

Each year, more than one million patients worldwide undergo cardiac surgery via sternotomy. Postoperative pain is frequent in this context, affecting 49% of patients at rest and 78% during mobilizatio...

Eligibility Criteria

Inclusion

  • Pre-inclusion criteria :
  • Adult patient (≥18 years old);
  • Patient having scheduled cardiac surgery with a sternotomy performed at the CHU d'Angers;
  • Patient having signed a consent;
  • French-speaking patient, able to understand and answer a questionnaire;
  • Affiliated patient or beneficiary of a social security scheme.
  • Criteria for confirming inclusion
  • Hemodynamic stability at the end of surgery;
  • Absence of bleeding justifying immediate revision surgery.
  • Non-inclusion criteria
  • Known hypersensitivity to amide-bonded local anesthetics;
  • Operation for cardiac revision surgery, including sternotomy REDUX (revision surgery);
  • Emergency surgery;
  • Surgery in a septic context (Endocarditis, Intravascular device infection);
  • Weight less than 30kg;
  • Severe psychiatric or cognitive impairment interfering with assessment by questionnaires;
  • Pregnant, breastfeeding or parturient woman;
  • Person deprived of liberty by judicial or administrative decision;
  • A person undergoing psychiatric treatment under duress;
  • Person subject to a measure of legal protection;
  • Inclusion in another interventional study modifying postoperative pain management.

Exclusion

    Key Trial Info

    Start Date :

    August 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 7 2023

    Estimated Enrollment :

    254 Patients enrolled

    Trial Details

    Trial ID

    NCT05345639

    Start Date

    August 1 2022

    End Date

    September 7 2023

    Last Update

    March 21 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Jeanneteau

    Angers, maine et loire, France, 49933